• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉血栓栓塞症的自然病史。

Natural history of venous thromboembolism.

作者信息

Kearon Clive

机构信息

McMaster Clinic, Henderson General Hospital, Hamilton, Ontario, Canada.

出版信息

Circulation. 2003 Jun 17;107(23 Suppl 1):I22-30. doi: 10.1161/01.CIR.0000078464.82671.78.

DOI:10.1161/01.CIR.0000078464.82671.78
PMID:12814982
Abstract

Most deep vein thromboses (DVTs) start in the calf, and most probably resolve spontaneously. Thrombi that remain confined to the calf rarely cause leg symptoms or symptomatic pulmonary embolism (PE). The probability that calf DVT will extend to involve the proximal veins and subsequently cause PE increases with the severity of the initiating prothrombotic stimulus. Although acute venous thromboembolism (VTE) usually presents with either leg or pulmonary symptoms, most patients have thrombosis at both sites at the time of diagnosis. Proximal DVTs resolve slowly during treatment with anticoagulants, and thrombi remain detectable in half of the patients after a year. Resolution of DVT is less likely in patients with a large initial thrombus or cancer. About 10% of patients with symptomatic DVTs develop severe post-thrombotic syndrome within 5 years, and recurrent ipsilateral DVT increases this risk. About 10% of PEs are rapidly fatal, and an additional 5% cause death later, despite diagnosis and treatment. About 50% of diagnosed PEs are associated with right ventricular dysfunction, which is associated with a approximately 5-fold greater in-hospital mortality. There is approximately 50% resolution of PE after 1 month of treatment, and perfusion eventually returns to normal in two thirds of patients. About 5% of treated patients with PE develop pulmonary hypertension as a result of poor resolution. After a course of treatment, the risk of recurrent thrombosis is higher (ie, approximately 10% per patient-year) in patients without reversible risk factors, in those with cancer, and in those with prothrombotic biochemical abnormalities such as antiphospholipid antibodies and homozygous factor V Leiden.

摘要

大多数深静脉血栓形成(DVT)始于小腿,且大多可能会自发消退。局限于小腿的血栓很少引起腿部症状或有症状的肺栓塞(PE)。小腿DVT扩展至累及近端静脉并随后导致PE的可能性会随着起始促血栓形成刺激的严重程度而增加。尽管急性静脉血栓栓塞症(VTE)通常表现为腿部或肺部症状,但大多数患者在诊断时两个部位都有血栓形成。近端DVT在抗凝治疗期间消退缓慢,一年后仍有一半患者的血栓可被检测到。初始血栓较大或患有癌症的患者中,DVT更不易消退。约10%有症状的DVT患者在5年内会发展为严重的血栓后综合征,同侧DVT复发会增加这种风险。约10%的PE会迅速致命,另有5%尽管经过诊断和治疗仍会在后期导致死亡。约50%已诊断的PE与右心室功能障碍有关,这与住院死亡率高出约5倍相关。治疗1个月后约50%的PE会消退,最终三分之二的患者灌注恢复正常。约5%接受治疗的PE患者因消退不佳而发展为肺动脉高压。经过一个疗程的治疗后,没有可逆性危险因素的患者、患有癌症的患者以及有促血栓形成生化异常(如抗磷脂抗体和纯合子因子V莱顿突变)的患者复发血栓形成的风险更高(即每位患者每年约10%)。

相似文献

1
Natural history of venous thromboembolism.静脉血栓栓塞症的自然病史。
Circulation. 2003 Jun 17;107(23 Suppl 1):I22-30. doi: 10.1161/01.CIR.0000078464.82671.78.
2
Natural history of venous thromboembolism.静脉血栓栓塞症的自然病史。
Semin Vasc Med. 2001;1(1):27-37. doi: 10.1055/s-2001-14539.
3
Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism.症状性肺栓塞与复发性静脉血栓栓塞的风险
Arch Intern Med. 2004 Jan 12;164(1):92-6. doi: 10.1001/archinte.164.1.92.
4
Multi-institutional study of symptomatic deep venous thrombosis and pulmonary embolism in prostate cancer patients undergoing laparoscopic or robot-assisted laparoscopic radical prostatectomy.对接受腹腔镜或机器人辅助腹腔镜根治性前列腺切除术的前列腺癌患者发生症状性深静脉血栓形成和肺栓塞的多机构研究。
Eur Urol. 2008 Jan;53(1):134-45. doi: 10.1016/j.eururo.2007.05.028. Epub 2007 Jun 11.
5
Burden of illness in venous thromboembolism in critical care: a multicenter observational study.重症监护中静脉血栓栓塞症的疾病负担:一项多中心观察性研究。
J Crit Care. 2005 Dec;20(4):341-7. doi: 10.1016/j.jcrc.2005.09.014.
6
Global Risk Profile Verification in Patients with Venous Thromboembolism (GRIP VTE) in 5 Gulf countries.海湾地区5个国家静脉血栓栓塞症患者的全球风险概况验证(GRIP VTE)
Clin Appl Thromb Hemost. 2009 May-Jun;15(3):289-96. doi: 10.1177/1076029608315168. Epub 2008 Apr 8.
7
The epidemiology of venous thromboembolism.静脉血栓栓塞症的流行病学
Circulation. 2003 Jun 17;107(23 Suppl 1):I4-8. doi: 10.1161/01.CIR.0000078468.11849.66.
8
Oral anticoagulant therapy in venous thromboembolism.静脉血栓栓塞症的口服抗凝治疗
Semin Vasc Med. 2003 Aug;3(3):303-14. doi: 10.1055/s-2003-44640.
9
Factors associated with the timing of diagnosis of venous thromboembolism: results from the MASTER registry.与静脉血栓栓塞症诊断时机相关的因素:MASTER注册研究结果
Thromb Res. 2008;121(6):751-6. doi: 10.1016/j.thromres.2007.08.009. Epub 2007 Oct 24.
10
Activated protein C resistance, factor V Leiden and assessment of thrombotic risk.活化蛋白C抵抗、凝血因子V莱顿突变与血栓形成风险评估
Ir Med J. 2008 Sep;101(8):256-7.

引用本文的文献

1
Clinical Outcomes and Disease Management for Patients with Paroxysmal Nocturnal Haemoglobinuria in China: Results from a Real-World Study.中国阵发性睡眠性血红蛋白尿症患者的临床结局与疾病管理:一项真实世界研究的结果
Drugs Real World Outcomes. 2025 Aug 23. doi: 10.1007/s40801-025-00512-y.
2
Development and validation of a nomogram prediction model for perioperative deep vein thrombosis risk in arthroplasty: a retrospective study.关节置换术中围手术期深静脉血栓形成风险列线图预测模型的构建与验证:一项回顾性研究
Front Med (Lausanne). 2025 May 22;12:1528154. doi: 10.3389/fmed.2025.1528154. eCollection 2025.
3
New evidence amid old assumptions for thromboembolic risk after total knee arthroplasty: a twist in the story.
全膝关节置换术后血栓栓塞风险的旧有假设下的新证据:故事出现转折。
Can J Anaesth. 2025 May 28. doi: 10.1007/s12630-025-02958-8.
4
Causal Relationship Between Immune Cells and Venous Thromboembolism: A Bidirectional Two-Sample Mendelian Randomization Study.免疫细胞与静脉血栓栓塞之间的因果关系:一项双向双样本孟德尔随机化研究。
Vasc Health Risk Manag. 2025 Mar 25;21:181-195. doi: 10.2147/VHRM.S497476. eCollection 2025.
5
Intraoperative Intermittent Pneumatic Compression Reduces Incidence of Venous Thromboembolism in Patients Undergoing Craniotomy: Study Protocol of a Randomized Multicenter, Single-Blind Trial.术中间歇性气动压迫降低开颅手术患者静脉血栓栓塞发生率:一项随机多中心单盲试验的研究方案
Neurosurg Pract. 2024 Aug 28;5(4):e00109. doi: 10.1227/neuprac.0000000000000109. eCollection 2024 Dec.
6
Anticoagulation at the end of life: whether, when, and how to treat.临终时的抗凝治疗:是否进行治疗、何时治疗以及如何治疗。
Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):348-354. doi: 10.1182/hematology.2024000559.
7
Rationale and design of the PE-TRACT trial: A multicenter randomized trial to evaluate catheter-directed therapy for the treatment of intermediate-risk pulmonary embolism.PE-TRACT试验的原理与设计:一项多中心随机试验,旨在评估导管导向治疗对中度风险肺栓塞的治疗效果。
Am Heart J. 2025 Mar;281:112-122. doi: 10.1016/j.ahj.2024.11.016. Epub 2024 Dec 3.
8
Influence of postoperative D-dimer evaluation and intraoperative use of intermittent pneumatic vein compression (IPC) on detection and development of perioperative venous thromboembolism in brain tumor surgery.术后 D-二聚体评估和术中使用间歇性气动静脉压迫(IPC)对脑肿瘤手术围手术期静脉血栓栓塞症的检测和发展的影响。
Acta Neurochir (Wien). 2024 Nov 26;166(1):480. doi: 10.1007/s00701-024-06379-2.
9
Etiology, Predisposing Factors, Clinical Profile, Diagnosis, Management, Outcome, and Way Forward in Pulmonary Embolism at a Tertiary Care Center in East India.印度东部一家三级医疗中心肺栓塞的病因、诱发因素、临床特征、诊断、管理、结局及未来方向
Cureus. 2024 Oct 21;16(10):e72000. doi: 10.7759/cureus.72000. eCollection 2024 Oct.
10
Approach to pulmonary embolism for frontline clinicians.一线临床医生对肺栓塞的诊疗方法
Singapore Med J. 2024 Sep 1;65(9):508-513. doi: 10.4103/singaporemedj.SMJ-2023-212. Epub 2024 Sep 6.